CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap $5.72MP/E –Yield –
CollPlant Biotechnologies pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
CollPlant Biotechnologies's pe ratio was 543.0× on Feb 28, 2023, against 7.7× a year earlier. Over the last 3 years it ranged from 1.9× to 561.0×, with a median of 3.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 543.0× | +125.5 |
| 2022 | Dec 30, 2022 | 417.5× | +409.8 |
| 2020 | Feb 28, 2020 | 7.7× | +3.7 |
| 2019 | Dec 31, 2019 | 4.0× | +2.1 |
| 2018 | Dec 31, 2018 | 1.9× | – |
See a number that looks wrong?